Home Latest News Acorda patents ruled invalid for MS drug Ampyra

Acorda patents ruled invalid for MS drug Ampyra

Previous articleMastercard to buy anti-fraud firm
Next articleSales Leads – 040317
As managing editor of the Business Journals, John Golden directs news coverage of Westchester and Fairfield counties and the Hudson Valley region. He was an award-winning upstate columnist and feature writer before joining the Business Journal in 2007. He is the author of “Northern Drift: Sketches on the New York Frontier,” a collection of his regional journalism.

LEAVE A REPLY

Please enter your comment!
Please enter your name here